These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4408919)

  • 1. [Clinical experience with oxyphedrine. Action on the heart and coronary therapy (author's transl)].
    Castillo Bernal A; Sáez de Santa María IE
    Folia Clin Int (Barc); 1974; 24(7):573-8. PubMed ID: 4408919
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].
    Diewitz M
    Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of myocardial contractions in chronic coronary insufficiency and under the effects of oxyphedrine].
    Ferreira Montero I; González Carretero M; Del Rio Ligorit A; La Figuera Benito E
    Rev Esp Cardiol; 1974; 27(5):391-9. PubMed ID: 4456468
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with oxyphedrine in the treatment of ischemic cardiopathy].
    Almeida SP
    Rev Bras Med; 1971 Dec; 28(12):644-52. PubMed ID: 5145755
    [No Abstract]   [Full Text] [Related]  

  • 5. [Global and regional left ventricular function in coronary heart disease after beta-blockade and furosemide (author's transl)].
    Nechwatal W; Sigel H; Bitter F; Geffers H; Kress P; Adam WE; Stauch M
    Dtsch Med Wochenschr; 1980 Nov; 105(48):1687-93. PubMed ID: 7439055
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of oxyphedrine on ventricular dynamics in ischemic cardiopathy].
    Barbosa J; Lopes AS; Lopes JS; Vergara M; Benchimol AB
    Arq Bras Cardiol; 1972 Jun; 25(3):231-9. PubMed ID: 5079398
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of oxyphedrin on hemodynamics and respiration].
    Jedlicka K; Krofta K
    Wien Med Wochenschr; 1974 May; 124(20):316-9. PubMed ID: 4829690
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trimepranol (VUFB) and practolol (eraldin ICI) in ischemic heart disease (author's transl)].
    Jedlicka K; Kuchar L; Jerábek M; Olbrichová Z
    Cas Lek Cesk; 1973 Dec; 112(51):1591-3. PubMed ID: 4588661
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oxyphedrine in the treatment of coronary insufficiency: clinical evaluation].
    França HH; Martins L
    Arq Bras Cardiol; 1971 Apr; 24(2):23-30. PubMed ID: 5162299
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ergometric dose-effect study of bunitrolol (Stresson) in patients with coronary heart disease (author's transl)].
    Böhm H; Höhm B; Ludwig B; Madl W; Werner F
    Wien Med Wochenschr; 1981 Sep; 131(18):457-61. PubMed ID: 6117988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immediate action of oxyphedrin as evaluated using the exertion test in coronary patients].
    Velasco Rami JA; Tormo Alfonso V; Roda Nicolas J; Serra Sister E
    Rev Esp Cardiol; 1977; 30(1):17-21. PubMed ID: 854620
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled clinical study of large doses of etaphenone in coronary insufficiency].
    Del Guerico R
    Clin Ter; 1975 Aug; 74(4):337-63. PubMed ID: 1227752
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the cardiovascular effects of the beta-blockader atenolol].
    Lucatti A; Delfino R; Musso G; Gazzarata M; Oldoino E; Spirito P
    Arch Sci Med (Torino); 1983; 140(2):177-82. PubMed ID: 6882193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fludilat treatment of vagotonic and subendocardial disturbances of cardiac metabolism and bradycardiac coronary diseases (author's transl)].
    Széplaki S; Széplaki Z
    MMW Munch Med Wochenschr; 1976 Mar; 118(10):309-12. PubMed ID: 817154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of atenolol on the exercise symptoms of coronary patients. A double blind study (author's transl)].
    Bischoff K
    MMW Munch Med Wochenschr; 1981 Sep; 123(36):1337-40. PubMed ID: 6792528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic value of oxyphedrin (Ildamen) in treatment of ischemic heart disease].
    Giec L; Mandecki T; Hermanowicz A
    Wiad Lek; 1973 Dec; 26(23):2201-5. PubMed ID: 4148957
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glycoside and coronary therapy with Ildamen-Novodigal].
    Moosdorf S; Reincke J
    Ther Ggw; 1974 Nov; 113(11):1921-39. PubMed ID: 4462219
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of the partial beta-adrenergic receptor agonist, oxyfedrine, on regional myocardial blood flow and left ventricular function in patients with coronary artery disease].
    Dirschinger J; Fleck E; Rudolph W
    Herz; 1982 Dec; 7(6):351-7. PubMed ID: 7160821
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical studies on application of Visken in treatment of coronary disease (author's transl)].
    Ziólkowski L; Ilmurzyńska K
    Przegl Lek; 1973; 30(9):771-5. PubMed ID: 4587262
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral oxyfedrine on left ventricular performance in patients of ischaemic heart disease.
    Puri VK; Mehrotra A; Agarwal SK; Hasan M
    J Assoc Physicians India; 1985 Apr; 33(4):269-71. PubMed ID: 4030673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.